Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Burns. 2022 Apr 22;49(2):408–414. doi: 10.1016/j.burns.2022.04.015

Table 2 –

Comparison of comorbidities and complications associated with tracheostomy [Cohort 1a] and without tracheostomy [Cohort 2a] when matching for age and pulmonary condition.

Outcome Cohort 1a n (%) Cohort 2a n (%) Risk Ratio 95% Confidence Interval P
Pneumonia 71 (46.7) 24 (15.8) 2.96 (1.97, 4.43) < 0.0001
Respiratory Failure 77 (50.7) 2 (14.5) 3.5 (2.31, 5.31) < 0.0001
Other Respiratory Disorders 97 (63.8) 31 (20.4) 3.13 (2.24, 4.38) < 0.0001
Hospital Visits 53 (34.9) 21 (13.8) 2.52 (1.6, 3.97) < 0.0001
Diseases of the Vocal Cords and Larynx 39 (25.6) 10 (6.58) 3.9 (2.02, 7.53) < 0.0001
Sepsis 25 (16.4) 10 (6.58) 2.5 (1.24, 5.02) 0.007
Volume Depletion 25 (16.4) 10 (6.58) 2.5 (1.24, 5.02) 0.007
Pulmonary Edema 33 (21.7) 10 (6.58) 3.3 (1.69, 6.45) 0.0002
Respiratory Arrest 10 (6.58) 0 (0) N/A N/A 0.0013
Death 16 (10.5) 10 (6.58) 1.6 (0.75, 3.41) 0.218
Infection of the Skin and Subcutaneous Tissue 29 (19.1) 19 (12.5) 1.53 (0.896, 2.60) 0.1157
Infection Following a Procedure 10 (6.58) 10 (6.58) 1 (0.429, 2.33) 1
Hypovolemic Shock 10 (6.58) 10 (6.58) 1 (0.429, 2.33) 1